Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;88(4):449-52.
doi: 10.15386/cjmed-491. Epub 2015 Nov 15.

Measurement of current perception thresholds using the Neurometer(®) - applicability in diabetic neuropathy

Georgeta Victoria Inceu  1 , Ioan Andrei Veresiu  1
Affiliations
Review

Measurement of current perception thresholds using the Neurometer(®) - applicability in diabetic neuropathy

Georgeta Victoria Inceu et al. Clujul Med. 2015.

Abstract

The incidence of diabetes mellitus is continuously growing worldwide, while the specific chronic complications that it induces have a negative impact on life expectancy andquality, entailing extremely high costs of healthcare services. Diabetic peripheral neuropathy is one of the most common chronic complications of diabetes, affecting almost half of diabetic people during life. This review aims at summarizing the evidence on the advantages and the usefulness of current perception threshold measurement for peripheral diabetic neuropathy assessment. Among the different methods used for the screening and diagnosis of diabetic neuropathy, measurement of current perception threshold using the Neurometer® has the ability to assess three sub-types of nerve fiber by producing transcutaneous electrical stimuli at frequencies of 2000, 250 and 5 Hz. Current evidence shows that this method provides a useful, noninvasive evaluation technique of patients with peripheral nervous system disorders, being able to detect neuropathy in the earliest and asymptomatic stages.

Keywords: Neurometer®; current perception threshold; diabetic neuropathies; peripheral nervous system.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Neurometer® device (Neurotron Inc., Baltimore, Maryland, USA).
Figure 2
Figure 2
R-CPT nerve evaluation in a patient without DPN (A) and a patient with sensory DPN (B).
See this image and copyright information in PMC

References

    1. International Diabetes Federation. IDF Diabetes Atlas. 6th edn. Brussels Belgium: International Diabetes Federation; 2013. Available from: http://www.idf.org/diabetesatlas.
    1. World Health Organization. GLOBAL STATUS REPORT on noncommunicable diseases. 2014. Available from: http://www.who.int/nmh/publications/ncd-status-report-2014/en/
    1. Boden-Albala B, Cammack S, Chong J, Wang C, Wright C, Rundek T, et al. Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS) Diabetes Care. 2008;31(6):1132–1137. - PubMed
    1. Boulton AJM. Management of diabetic peripheral neuropathy. Clin Diabetes. 2005;23(1):9–15.
    1. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ, 3rd, O’Brien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care. 1999;22(9):1479–1486. - PubMed

LinkOut - more resources